US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Prelude Therapeutics Inc

3.56

-0.1800-4.81%

Post-market: 3.54-0.0200-0.56%19:55 EDT

Volume:676.36K

Turnover:2.44M

Market Cap:283.53M

PE:-4.96

High:3.90

Open:3.74

Low:3.43

Close:3.74

52wk High:6.83

52wk Low:1.16

Shares:79.64M

Float Shares:4.56M

Volume Ratio:1.88

T/O Rate:14.84%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.7183

EPS(LYR):-1.2929

ROE:-57.73%

ROA:-27.15%

PB:2.12

PE(LYR):-2.75

Loading ...

Overview Company News Filings

Analysts Offer Insights on Healthcare Companies: NovaBridge Biosciences (NBP) and Prelude Therapeutics (PRLD)

H.C. Wainwright ‘highly enthusiastic’ on Prelude collaboration with Lilly

Prelude Therapeutics Partners with Lilly to Test Prt13722 Combos with Verzenio, Imlunestrant in Phase 1 Breast Cancer Trial

Prelude Announces Clinical Trial Collaboration and Supply Agreement with Lilly to Evaluate Kat6a Selective Degrader Prt13722 in Combination with Verzenio® and Inluriyo® in Patients with Hr+/Her2- Breast Cancer

THOMSON REUTERS

Prelude Therapeutics Incorporated - Agreement Supports Evaluation of Prt13722 with Abemaciclib and Imlunestrant in Phase 1 Trial

THOMSON REUTERS

Prelude Therapeutics Incorporated - Maintains Full Global Development and Commercial Rights to Prt13722

THOMSON REUTERS

Prelude Therapeutics Incorporated : JP Morgan Initiates Coverage with Overweight Rating; Price Target $12

THOMSON REUTERS

Prelude Therapeutics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

Prelude Therapeutics IND Cleared for Novel Breast Cancer Drug

Prelude Therapeutics receives FDA clearance for PRT13722 IND application

Prelude Therapeutics Says FDA Clears IND for Prt13722 in Hr+/her2- Breast Cancer

Prelude Therapeutics Incorporated - Expects to Begin Enrolling Patients in Q4 2026

THOMSON REUTERS

Prelude Therapeutics Receives FDA Clearance of Investigational New Drug (Ind) Application for Prt13722, Its First-in-Class Oral Kat6a Selective Degrader

THOMSON REUTERS

Prelude Therapeutics Stock Rises on Narrower 2Q Loss, Plans to Start Trial for Breast Cancer Drug

Calendar of U.S. Earnings Expected in the Week Ahead

Ovid Therapeutics Q2 Revenue Beats Estimates

Prelude Therapeutics Incorporated Reports Results for the Quarter Ended June 30 - Earnings Summary

Cardiff Oncology Q2 Operating Expenses Fall on Lower R&D Costs

Bolt Biotherapeutics Q2 Net Loss Narrows on Restructuring and Lower Research Activity

Prelude Therapeutics Q2 EPS $(0.14) Beats $(0.20) Estimate, Sales $5.704M

Benzinga Earnings

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigermarketb.com/stock/PRLD/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PRLD","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PRLD\",,,,,undefined,":{"symbol":"PRLD","market":"US","secType":"STK","nameCN":"Prelude Therapeutics Inc","latestPrice":3.56,"timestamp":1791921600000,"preClose":3.74,"halted":0,"volume":676363,"hourTrading":{"tag":"盘后","latestPrice":3.54,"preClose":3.56,"latestTime":"19:55 EDT","volume":9153,"amount":32772.238,"timestamp":1791935754851,"change":-0.02,"changeRate":-0.005618,"amplitude":0.058989},"delay":0,"changeRate":-0.048128342245989345,"floatShares":4557900,"shares":79642905,"eps":-0.718297,"marketStatus":"Closed","change":-0.18,"latestTime":"10-13 16:00:00 EDT","open":3.74,"high":3.897,"low":3.43,"amount":2442491.6699546,"amplitude":0.124866,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.718297,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791964800000},"marketStatusCode":5,"adr":0,"listingDate":1601006400000,"exchange":"NASDAQ","adjPreClose":3.74,"preHourTrading":{"tag":"盘前","latestPrice":3.8156,"preClose":3.74,"latestTime":"09:24 EDT","volume":19681,"amount":76373.1163586,"timestamp":1791897860163,"change":0.0756,"changeRate":0.020214,"amplitude":0.157754},"postHourTrading":{"tag":"盘后","latestPrice":3.54,"preClose":3.56,"latestTime":"19:55 EDT","volume":9153,"amount":32772.238,"timestamp":1791935754851,"change":-0.02,"changeRate":-0.005618,"amplitude":0.058989},"volumeRatio":1.878026,"impliedVol":1.9665,"impliedVolPercentile":0.6892},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PRLD\",,,,,undefined,":{"symbol":"PRLD","floatShares":4557900,"roa":"-27.15%","roe":"-57.73%","lyrEps":-1.292917,"volumeRatio":1.878026,"shares":79642905,"dividePrice":0,"high":3.897,"amplitude":0.124866,"preClose":3.74,"low":3.43,"week52Low":1.16,"pbRate":"2.12","psRate":"12.64","week52High":6.83,"institutionHeld":0,"latestPrice":3.56,"eps":-0.718297,"divideRate":0,"volume":676363,"delay":0,"ttmEps":-0.718297,"open":3.74,"prevYearClose":2.9,"prevWeekClose":3.89,"prevMonthClose":3.91,"prevQuarterClose":3.91,"fiveDayClose":3.81,"twentyDayClose":4.52,"sixtyDayClose":4.06},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PRLD\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-11","symbol":"PRLD","fiscalQuarterEnding":"2026/06","expectedEps":-0.17,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1786420800000,"reportTimeType":"pre","actualEps":-0.14},{"market":"US","date":"2026-05-12","symbol":"PRLD","fiscalQuarterEnding":"2026/03","expectedEps":-0.27,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778558400000,"reportTimeType":"pre","actualEps":-0.13},{"market":"US","date":"2026-03-10","symbol":"PRLD","fiscalQuarterEnding":"2025/12","expectedEps":-0.33,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1773115200000,"reportTimeType":"pre","actualEps":-0.2},{"market":"US","date":"2025-11-12","symbol":"PRLD","fiscalQuarterEnding":"2025/09","expectedEps":-0.35,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"pre","actualEps":-0.26},{"market":"US","date":"2025-08-14","symbol":"PRLD","fiscalQuarterEnding":"2025/06","expectedEps":-0.45,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1755144000000,"reportTimeType":"pre","actualEps":-0.41}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PRLD\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PRLD\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2,"buy":0.8,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.8,"analysts":5,"updateTime":1790740800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PRLD\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PRLD","date":"2026-10-12","current":-4.956167,"percent":0.059211,"low":-11.289121,"twenty":-3.355365,"median":-2.068107,"eighty":-0.756508,"high":-0.264772,"avg":-2.569035,"sd":2.167156,"marketCap":400650258},"quantilePoints":[{"date":"2021-10-15","current":-8.934368,"twenty":-55.395739,"median":-31.977203,"eighty":-20.05702,"marketCap":752050463},{"date":"2021-10-22","current":-9.6267,"twenty":-55.070687,"median":-31.313219,"eighty":-19.592288,"marketCap":810327436},{"date":"2021-10-29","current":-9.659668,"twenty":-54.896793,"median":-31.28134,"eighty":-19.135611,"marketCap":813102530},{"date":"2021-11-05","current":-9.43988,"twenty":-54.595131,"median":-29.763099,"eighty":-18.972569,"marketCap":794601903},{"date":"2021-11-12","current":-7.657834,"twenty":-54.096156,"median":-29.527991,"eighty":-18.79624,"marketCap":751248869},{"date":"2021-11-19","current":-6.835326,"twenty":-53.456784,"median":-28.442844,"eighty":-18.666566,"marketCap":670559176},{"date":"2021-11-26","current":-6.617882,"twenty":-53.161294,"median":-28.201498,"eighty":-18.548531,"marketCap":649227418},{"date":"2021-12-03","current":-6.570611,"twenty":-53.053392,"median":-27.936468,"eighty":-18.184132,"marketCap":644590079},{"date":"2021-12-10","current":-6.52334,"twenty":-52.903151,"median":-27.280379,"eighty":-17.91197,"marketCap":639952740},{"date":"2021-12-17","current":-6.47607,"twenty":-52.38608,"median":-26.338379,"eighty":-17.539055,"marketCap":635315401},{"date":"2021-12-23","current":-6.490251,"twenty":-51.489304,"median":-26.061142,"eighty":-17.383006,"marketCap":636706603},{"date":"2021-12-31","current":-5.885188,"twenty":-50.620381,"median":-25.884108,"eighty":-16.989586,"marketCap":577348668},{"date":"2022-01-07","current":-4.750694,"twenty":-50.050635,"median":-25.08883,"eighty":-15.813722,"marketCap":466052539},{"date":"2022-01-14","current":-4.500159,"twenty":-49.533133,"median":-23.673783,"eighty":-10.067374,"marketCap":441474644},{"date":"2022-01-21","current":-4.192901,"twenty":-49.263626,"median":-23.205723,"eighty":-9.879455,"marketCap":411331942},{"date":"2022-01-28","current":-4.575792,"twenty":-48.949202,"median":-22.720947,"eighty":-9.659668,"marketCap":448894386},{"date":"2022-02-04","current":-4.651425,"twenty":-48.816067,"median":-22.30638,"eighty":-9.511311,"marketCap":456314128},{"date":"2022-02-11","current":-4.727058,"twenty":-48.544941,"median":-22.105783,"eighty":-9.209103,"marketCap":463733870},{"date":"2022-02-18","current":-4.741239,"twenty":-46.994903,"median":-22.06232,"eighty":-8.720075,"marketCap":465125071},{"date":"2022-02-25","current":-4.911414,"twenty":-46.680777,"median":-22.025545,"eighty":-8.38015,"marketCap":481819490},{"date":"2022-03-04","current":-3.715468,"twenty":-46.54883,"median":-21.68453,"eighty":-7.321268,"marketCap":364494821},{"date":"2022-03-11","current":-4.207082,"twenty":-46.38227,"median":-21.651097,"eighty":-6.817363,"marketCap":412723144},{"date":"2022-03-18","current":-3.5488,"twenty":-46.018986,"median":-21.423754,"eighty":-6.719986,"marketCap":396379721},{"date":"2022-03-25","current":-3.081521,"twenty":-45.93774,"median":-21.393664,"eighty":-6.518613,"marketCap":344187373},{"date":"2022-04-01","current":-3.052053,"twenty":-45.930633,"median":-21.330142,"eighty":-6.473234,"marketCap":340895964},{"date":"2022-04-08","current":-2.770001,"twenty":-45.765395,"median":-21.226726,"eighty":-6.38531,"marketCap":309392475},{"date":"2022-04-14","current":-2.517417,"twenty":-45.458018,"median":-21.04262,"eighty":-6.263352,"marketCap":281180395},{"date":"2022-04-22","current":-2.189058,"twenty":-45.061805,"median":-20.882142,"eighty":-5.916386,"marketCap":244504691},{"date":"2022-04-29","current":-1.934891,"twenty":-44.897885,"median":-20.772909,"eighty":-5.533494,"marketCap":216115702},{"date":"2022-05-06","current":-1.804212,"twenty":-44.660987,"median":-20.735037,"eighty":-4.940721,"marketCap":201519652},{"date":"2022-05-13","current":-1.818605,"twenty":-44.492947,"median":-20.675024,"eighty":-4.861307,"marketCap":217976210},{"date":"2022-05-20","current":-1.783178,"twenty":-44.427507,"median":-20.539157,"eighty":-4.769602,"marketCap":213729920},{"date":"2022-05-27","current":-1.798923,"twenty":-44.390814,"median":-20.236949,"eighty":-4.727058,"marketCap":215617160},{"date":"2022-06-03","current":-1.869778,"twenty":-44.38726,"median":-20.09647,"eighty":-4.660879,"marketCap":224109740},{"date":"2022-06-10","current":-1.806796,"twenty":-44.265356,"median":-19.832351,"eighty":-4.599428,"marketCap":216560780},{"date":"2022-06-17","current":-1.865842,"twenty":-44.043029,"median":-19.587722,"eighty":-4.48976,"marketCap":223637930},{"date":"2022-06-24","current":-2.149261,"twenty":-43.92505,"median":-19.423735,"eighty":-4.398055,"marketCap":257608249},{"date":"2022-07-01","current":-2.086279,"twenty":-43.696148,"median":-19.123575,"eighty":-4.259079,"marketCap":250059289},{"date":"2022-07-08","current":-2.133515,"twenty":-43.570722,"median":-19.033611,"eighty":-4.188174,"marketCap":255721009},{"date":"2022-07-15","current":-2.054788,"twenty":-43.210436,"median":-18.956686,"eighty":-4.131449,"marketCap":246284809},{"date":"2022-07-22","current":-2.326398,"twenty":-42.499738,"median":-18.802834,"eighty":-3.800555,"marketCap":278839698},{"date":"2022-07-29","current":-1.968188,"twenty":-42.490855,"median":-18.752811,"eighty":-3.519332,"marketCap":235904990},{"date":"2022-08-05","current":-2.428743,"twenty":-42.348715,"median":-18.643488,"eighty":-3.132037,"marketCap":291106757},{"date":"2022-08-12","current":-3.419717,"twenty":-41.92895,"median":-18.551874,"eighty":-3.127828,"marketCap":411624506},{"date":"2022-08-19","current":-3.332942,"twenty":-41.673552,"median":-18.429195,"eighty":-3.132037,"marketCap":401179593},{"date":"2022-08-26","current":-3.068673,"twenty":-41.268253,"median":-18.106841,"eighty":-3.132037,"marketCap":369370087},{"date":"2022-09-02","current":-3.025286,"twenty":-40.493421,"median":-18.000232,"eighty":-3.09836,"marketCap":364147631},{"date":"2022-09-09","current":-3.056841,"twenty":-40.439519,"median":-17.676423,"eighty":-3.078951,"marketCap":367945781},{"date":"2022-09-16","current":-2.737351,"twenty":-40.315362,"median":-17.547297,"eighty":-3.05542,"marketCap":329489512},{"date":"2022-09-23","current":-2.615078,"twenty":-39.706639,"median":-17.440151,"eighty":-3.025286,"marketCap":314771681},{"date":"2022-09-30","current":-2.607189,"twenty":-39.434302,"median":-17.204438,"eighty":-2.978743,"marketCap":313822143},{"date":"2022-10-07","current":-2.749184,"twenty":-39.331969,"median":-16.978597,"eighty":-2.906508,"marketCap":330913818},{"date":"2022-10-14","current":-2.591412,"twenty":-39.11669,"median":-16.159887,"eighty":-2.811504,"marketCap":311923068},{"date":"2022-10-21","current":-2.449417,"twenty":-39.058296,"median":-10.401451,"eighty":-2.765838,"marketCap":294831393},{"date":"2022-10-28","current":-2.658465,"twenty":-38.903329,"median":-10.069022,"eighty":-2.698697,"marketCap":319994137},{"date":"2022-11-04","current":-2.906957,"twenty":-38.326135,"median":-9.88495,"eighty":-2.664776,"marketCap":349904568},{"date":"2022-11-11","current":-3.352664,"twenty":-37.864261,"median":-9.780551,"eighty":-2.682131,"marketCap":403553437},{"date":"2022-11-18","current":-2.959349,"twenty":-37.65144,"median":-9.659668,"eighty":-2.686075,"marketCap":354053589},{"date":"2022-11-25","current":-2.712737,"twenty":-37.288534,"median":-9.560763,"eighty":-2.663198,"marketCap":324549123},{"date":"2022-12-02","current":-2.820133,"twenty":-36.852831,"median":-9.48109,"eighty":-2.653073,"marketCap":337397842},{"date":"2022-12-09","current":-1.980855,"twenty":-36.670634,"median":-9.428891,"eighty":-2.639197,"marketCap":236987483},{"date":"2022-12-16","current":-2.05643,"twenty":-36.454373,"median":-8.923379,"eighty":-2.628289,"marketCap":246029174},{"date":"2022-12-23","current":-2.028586,"twenty":-35.905158,"median":-8.720075,"eighty":-2.619811,"marketCap":242698024},{"date":"2022-12-30","current":-2.402482,"twenty":-35.421187,"median":-8.637655,"eighty":-2.610345,"marketCap":287430601},{"date":"2023-01-06","current":-1.833683,"twenty":-35.056154,"median":-7.657834,"eighty":-2.592607,"marketCap":219379979},{"date":"2023-01-13","current":-2.39055,"twenty":-34.755654,"median":-7.449844,"eighty":-2.578956,"marketCap":286002966},{"date":"2023-01-20","current":-2.899685,"twenty":-34.533005,"median":-6.927504,"eighty":-2.578326,"marketCap":346915411},{"date":"2023-01-27","current":-2.553632,"twenty":-33.943242,"median":-6.825872,"eighty":-2.578326,"marketCap":305513984},{"date":"2023-02-03","current":-2.8082,"twenty":-33.834353,"median":-6.759693,"eighty":-2.57169,"marketCap":335970206},{"date":"2023-02-10","current":-2.374639,"twenty":-33.755747,"median":-6.617882,"eighty":-2.567746,"marketCap":284099452},{"date":"2023-02-17","current":-2.32293,"twenty":-33.389496,"median":-6.532794,"eighty":-2.537722,"marketCap":277913032},{"date":"2023-02-24","current":-2.199624,"twenty":-33.33518,"median":-6.499705,"eighty":-2.513283,"marketCap":263160799},{"date":"2023-03-03","current":-2.434303,"twenty":-33.273641,"median":-6.47607,"eighty":-2.462582,"marketCap":291237629},{"date":"2023-03-10","current":-2.398505,"twenty":-33.254795,"median":-6.445344,"eighty":-2.433191,"marketCap":286954723},{"date":"2023-03-17","current":-2.785679,"twenty":-32.950851,"median":-6.286987,"eighty":-2.426673,"marketCap":321573171},{"date":"2023-03-24","current":-2.661687,"twenty":-32.766675,"median":-6.260988,"eighty":-2.433191,"marketCap":307259825},{"date":"2023-03-31","current":-2.355841,"twenty":-32.675325,"median":-5.979729,"eighty":-2.433191,"marketCap":271953572},{"date":"2023-04-06","current":-2.574893,"twenty":-32.61644,"median":-5.885188,"eighty":-2.432079,"marketCap":297240483},{"date":"2023-04-14","current":-3.331242,"twenty":-32.534426,"median":-5.67247,"eighty":-2.436272,"marketCap":384551893},{"date":"2023-04-21","current":-2.471742,"twenty":-32.489159,"median":-5.010682,"eighty":-2.444684,"marketCap":285332943},{"date":"2023-04-28","current":-2.376675,"twenty":-32.47311,"median":-4.937412,"eighty":-2.436272,"marketCap":274358599},{"date":"2023-05-05","current":-2.52339,"twenty":-32.418128,"median":-4.887778,"eighty":-2.444684,"marketCap":291295062},{"date":"2023-05-12","current":-2.755377,"twenty":-32.36554,"median":-4.821599,"eighty":-2.455267,"marketCap":313261575},{"date":"2023-05-19","current":-2.347198,"twenty":-32.127148,"median":-4.769602,"eighty":-2.455267,"marketCap":266855336},{"date":"2023-05-26","current":-3.013371,"twenty":-31.669668,"median":-4.745966,"eighty":-2.460955,"marketCap":342593215},{"date":"2023-06-02","current":-3.185237,"twenty":-31.410451,"median":-4.727058,"eighty":-2.462365,"marketCap":362132752},{"date":"2023-06-09","current":-3.170915,"twenty":-31.322783,"median":-4.684515,"eighty":-2.463378,"marketCap":360504457},{"date":"2023-06-16","current":-3.030558,"twenty":-31.294091,"median":-4.651425,"eighty":-2.466386,"marketCap":344547169},{"date":"2023-06-23","current":-2.864422,"twenty":-31.28134,"median":-4.613609,"eighty":-2.467433,"marketCap":325658950},{"date":"2023-06-30","current":-2.583708,"twenty":-31.28134,"median":-4.575792,"eighty":-2.47088,"marketCap":293744372},{"date":"2023-07-07","current":-2.509233,"twenty":-30.684116,"median":-4.495432,"eighty":-2.481662,"marketCap":285277240},{"date":"2023-07-14","current":-2.658183,"twenty":-29.993765,"median":-4.424526,"eighty":-2.491691,"marketCap":302211505},{"date":"2023-07-21","current":-2.618081,"twenty":-29.755926,"median":-4.329985,"eighty":-2.495636,"marketCap":297652280},{"date":"2023-07-28","current":-2.388928,"twenty":-29.663783,"median":-4.273261,"eighty":-2.481662,"marketCap":271599564},{"date":"2023-08-04","current":-2.01396,"twenty":-29.565387,"median":-4.192901,"eighty":-2.462473,"marketCap":235125761},{"date":"2023-08-11","current":-1.696938,"twenty":-29.121533,"median":-4.178719,"eighty":-2.436272,"marketCap":198114169},{"date":"2023-08-18","current":-1.617248,"twenty":-28.672121,"median":-4.131449,"eighty":-2.416802,"marketCap":188810464},{"date":"2023-08-25","current":-1.678188,"twenty":-28.42078,"median":-3.85728,"eighty":-2.403246,"marketCap":195925062},{"date":"2023-09-01","current":-1.748503,"twenty":-28.308617,"median":-3.715468,"eighty":-2.39221,"marketCap":204134212},{"date":"2023-09-08","current":-1.73444,"twenty":-28.256205,"median":-3.606135,"eighty":-2.389252,"marketCap":202492382},{"date":"2023-09-15","current":-1.495368,"twenty":-28.110318,"median":-3.499107,"eighty":-2.374639,"marketCap":174581270},{"date":"2023-09-22","current":-1.307861,"twenty":-28.104968,"median":-3.419717,"eighty":-2.36651,"marketCap":152690202},{"date":"2023-09-29","current":-1.425053,"twenty":-28.035428,"median":-3.379847,"eighty":-2.355841,"marketCap":166372119},{"date":"2023-10-06","current":-1.303174,"twenty":-27.788852,"median":-3.358296,"eighty":-2.336919,"marketCap":152142925},{"date":"2023-10-13","current":-1.157856,"twenty":-27.560997,"median":-3.350691,"eighty":-2.323624,"marketCap":135177347},{"date":"2023-10-17","current":-1.14848,"twenty":-27.548136,"median":-3.340831,"eighty":-2.315376,"marketCap":134082793},{"date":"2023-10-23","current":-1.120354,"twenty":-27.541705,"median":-3.332942,"eighty":-2.309926,"marketCap":130799133},{"date":"2023-11-01","current":-0.792217,"twenty":-27.331358,"median":-3.327109,"eighty":-2.297473,"marketCap":92489763},{"date":"2023-11-10","current":-1.408979,"twenty":-26.805518,"median":-3.277722,"eighty":-2.281287,"marketCap":165411307},{"date":"2023-11-17","current":-1.586268,"twenty":-26.420694,"median":-3.261222,"eighty":-2.232471,"marketCap":186224650},{"date":"2023-11-24","current":-1.553609,"twenty":-26.306283,"median":-3.250967,"eighty":-2.220308,"marketCap":182390613},{"date":"2023-12-01","current":-1.544278,"twenty":-26.154549,"median":-3.202423,"eighty":-2.191171,"marketCap":181295174},{"date":"2023-12-08","current":-1.51162,"twenty":-26.036351,"median":-3.190064,"eighty":-2.16973,"marketCap":177461137},{"date":"2023-12-15","current":-1.871051,"twenty":-25.927824,"median":-3.178344,"eighty":-2.145002,"marketCap":219657642},{"date":"2023-12-22","current":-2.168859,"twenty":-25.887871,"median":-3.169482,"eighty":-2.145002,"marketCap":254619757},{"date":"2023-12-29","current":-2.216938,"twenty":-25.880345,"median":-3.149387,"eighty":-2.148196,"marketCap":260264037},{"date":"2024-01-05","current":-2.013941,"twenty":-25.804515,"median":-3.14151,"eighty":-2.137684,"marketCap":236432632},{"date":"2024-01-12","current":-2.067361,"twenty":-25.452251,"median":-3.131782,"eighty":-2.122726,"marketCap":242704054},{"date":"2024-01-19","current":-1.821628,"twenty":-24.897426,"median":-3.114476,"eighty":-2.10257,"marketCap":213855510},{"date":"2024-01-26","current":-1.784234,"twenty":-24.123788,"median":-3.103801,"eighty":-2.080153,"marketCap":209465514},{"date":"2024-02-02","current":-1.74684,"twenty":-23.924529,"median":-3.09836,"eighty":-2.068796,"marketCap":205075519},{"date":"2024-02-09","current":-1.431661,"twenty":-23.253197,"median":-3.084193,"eighty":-2.059856,"marketCap":168074125},{"date":"2024-02-16","current":-1.567976,"twenty":-23.227789,"median":-3.068673,"eighty":-2.054788,"marketCap":191029679},{"date":"2024-02-23","current":-1.743698,"twenty":-23.168947,"median":-3.062767,"eighty":-2.048708,"marketCap":212438177},{"date":"2024-03-01","current":-1.937442,"twenty":-22.77444,"median":-3.054579,"eighty":-2.027233,"marketCap":236042419},{"date":"2024-03-08","current":-1.973487,"twenty":-22.720947,"median":-3.041063,"eighty":-2.019283,"marketCap":240433906},{"date":"2024-03-15","current":-2.009533,"twenty":-22.587216,"median":-3.027258,"eighty":-2.013941,"marketCap":244825393},{"date":"2024-03-22","current":-2.171737,"twenty":-22.32644,"median":-3.025286,"eighty":-2.01396,"marketCap":264587084},{"date":"2024-03-28","current":-2.149209,"twenty":-22.294344,"median":-3.022585,"eighty":-2.018218,"marketCap":261842405},{"date":"2024-04-05","current":-2.135692,"twenty":-22.179335,"median":-3.002957,"eighty":-2.019283,"marketCap":260195597},{"date":"2024-04-12","current":-2.351964,"twenty":-22.115144,"median":-2.966121,"eighty":-2.019283,"marketCap":286544518},{"date":"2024-04-19","current":-1.549954,"twenty":-22.073688,"median":-2.951242,"eighty":-2.019283,"marketCap":188833935},{"date":"2024-04-26","current":-1.820294,"twenty":-22.065664,"median":-2.919573,"eighty":-2.012047,"marketCap":221770087},{"date":"2024-05-03","current":-1.79806,"twenty":-22.060314,"median":-2.906957,"eighty":-2.002245,"marketCap":219061210},{"date":"2024-05-10","current":-1.780743,"twenty":-22.048279,"median":-2.899685,"eighty":-1.986466,"marketCap":223563337},{"date":"2024-05-17","current":-1.872624,"twenty":-22.013509,"median":-2.882412,"eighty":-1.973214,"marketCap":235098546},{"date":"2024-05-24","current":-1.767617,"twenty":-21.903849,"median":-2.863886,"eighty":-1.967539,"marketCap":221915450},{"date":"2024-05-31","current":-1.693237,"twenty":-21.762094,"median":-2.859625,"eighty":-1.946749,"marketCap":212577424},{"date":"2024-06-07","current":-1.653859,"twenty":-21.672494,"median":-2.837931,"eighty":-1.922257,"marketCap":207633763},{"date":"2024-06-14","current":-1.706363,"twenty":-21.66447,"median":-2.831478,"eighty":-1.913431,"marketCap":214225311},{"date":"2024-06-21","current":-1.621045,"twenty":-21.659121,"median":-2.822121,"eighty":-1.883588,"marketCap":203514045},{"date":"2024-06-28","current":-1.614482,"twenty":-21.648422,"median":-2.816213,"eighty":-1.881108,"marketCap":202690102},{"date":"2024-07-05","current":-1.583855,"twenty":-21.602954,"median":-2.808275,"eighty":-1.876164,"marketCap":198845032},{"date":"2024-07-12","current":-1.73699,"twenty":-21.49998,"median":-2.793082,"eighty":-1.86981,"marketCap":218070380},{"date":"2024-07-15","current":-1.995132,"twenty":-21.474572,"median":-2.792686,"eighty":-1.869825,"marketCap":250478825},{"date":"2024-08-02","current":-2.472038,"twenty":-21.449163,"median":-2.792289,"eighty":-1.869841,"marketCap":310352053},{"date":"2024-08-09","current":-2.380157,"twenty":-21.423754,"median":-2.783114,"eighty":-1.870812,"marketCap":298816844},{"date":"2024-08-16","current":-2.444986,"twenty":-21.402356,"median":-2.770001,"eighty":-1.872309,"marketCap":317491191},{"date":"2024-08-23","current":-2.368712,"twenty":-21.391658,"median":-2.74665,"eighty":-1.874014,"marketCap":307586787},{"date":"2024-08-30","current":-2.203453,"twenty":-21.374273,"median":-2.737351,"eighty":-1.877967,"marketCap":286127244},{"date":"2024-09-06","current":-2.038194,"twenty":-21.34619,"median":-2.713374,"eighty":-1.878868,"marketCap":264667700},{"date":"2024-09-13","current":-2.046669,"twenty":-21.290022,"median":-2.707247,"eighty":-1.879781,"marketCap":265768190},{"date":"2024-09-20","current":-1.08054,"twenty":-21.2475,"median":-2.694751,"eighty":-1.871995,"marketCap":140312398},{"date":"2024-09-27","current":-0.936468,"twenty":-21.224675,"median":-2.690714,"eighty":-1.868025,"marketCap":121604078},{"date":"2024-10-04","current":-0.800871,"twenty":-21.152279,"median":-2.686075,"eighty":-1.851139,"marketCap":103996248},{"date":"2024-10-11","current":-0.822058,"twenty":-21.029246,"median":-2.671132,"eighty":-1.839338,"marketCap":106747471},{"date":"2024-10-18","current":-0.813583,"twenty":-20.94767,"median":-2.663912,"eighty":-1.822225,"marketCap":105646982},{"date":"2024-10-25","current":-0.656799,"twenty":-20.900864,"median":-2.660076,"eighty":-1.814534,"marketCap":85287928},{"date":"2024-10-31","current":-0.559338,"twenty":-20.874118,"median":-2.658324,"eighty":-1.804768,"marketCap":72632300},{"date":"2024-11-08","current":-0.531383,"twenty":-20.836212,"median":-2.653073,"eighty":-1.799381,"marketCap":69885904},{"date":"2024-11-15","current":-0.431018,"twenty":-20.777809,"median":-2.648777,"eighty":-1.789493,"marketCap":56686225},{"date":"2024-11-22","current":-0.404739,"twenty":-20.745736,"median":-2.645155,"eighty":-1.7836,"marketCap":53230016},{"date":"2024-11-29","current":-0.439388,"twenty":-20.740387,"median":-2.640997,"eighty":-1.772944,"marketCap":57786928},{"date":"2024-12-06","current":-0.39185,"twenty":-20.729328,"median":-2.638744,"eighty":-1.764044,"marketCap":51534933},{"date":"2024-12-13","current":-0.370425,"twenty":-20.706491,"median":-2.630944,"eighty":-1.753658,"marketCap":48717132},{"date":"2024-12-20","current":-0.371596,"twenty":-20.693904,"median":-2.628201,"eighty":-1.748826,"marketCap":48871230},{"date":"2024-12-27","current":-0.58585,"twenty":-20.643556,"median":-2.626891,"eighty":-1.743698,"marketCap":77049238},{"date":"2025-01-03","current":-0.52308,"twenty":-20.561613,"median":-2.623388,"eighty":-1.740299,"marketCap":68793962},{"date":"2025-01-10","current":-0.477049,"twenty":-20.539945,"median":-2.622109,"eighty":-1.736656,"marketCap":62740093},{"date":"2025-01-17","current":-0.426834,"twenty":-20.440252,"median":-2.618081,"eighty":-1.731754,"marketCap":56135873},{"date":"2025-01-24","current":-0.477049,"twenty":-20.33915,"median":-2.615078,"eighty":-1.724505,"marketCap":62740093},{"date":"2025-01-31","current":-0.497973,"twenty":-20.246839,"median":-2.61161,"eighty":-1.719745,"marketCap":65491852},{"date":"2025-02-07","current":-0.464495,"twenty":-20.160447,"median":-2.603245,"eighty":-1.712323,"marketCap":61089038},{"date":"2025-02-14","current":-0.397541,"twenty":-20.101151,"median":-2.591419,"eighty":-1.705008,"marketCap":52283411},{"date":"2025-02-21","current":-0.377664,"twenty":-20.065044,"median":-2.589437,"eighty":-1.699238,"marketCap":49669240},{"date":"2025-02-28","current":-0.311756,"twenty":-19.992829,"median":-2.588983,"eighty":-1.693237,"marketCap":41001201},{"date":"2025-03-07","current":-0.297988,"twenty":-19.790189,"median":-2.582592,"eighty":-1.684825,"marketCap":39190544},{"date":"2025-03-14","current":-0.306581,"twenty":-19.619345,"median":-2.574893,"eighty":-1.676528,"marketCap":38988810},{"date":"2025-03-21","current":-0.319418,"twenty":-19.601421,"median":-2.569718,"eighty":-1.66975,"marketCap":40621387},{"date":"2025-03-28","current":-0.295695,"twenty":-19.553142,"median":-2.560793,"eighty":-1.658293,"marketCap":37604429},{"date":"2025-04-04","current":-0.307101,"twenty":-19.473187,"median":-2.553863,"eighty":-1.649484,"marketCap":39054996},{"date":"2025-04-11","current":-0.278347,"twenty":-19.301778,"median":-2.549335,"eighty":-1.632518,"marketCap":35398244},{"date":"2025-04-17","current":-0.333947,"twenty":-19.143635,"median":-2.545961,"eighty":-1.621045,"marketCap":42469068},{"date":"2025-04-25","current":-0.373674,"twenty":-19.123575,"median":-2.537799,"eighty":-1.614482,"marketCap":47521232},{"date":"2025-05-02","current":-0.407695,"twenty":-19.05671,"median":-2.533744,"eighty":-1.586268,"marketCap":51847776},{"date":"2025-05-09","current":-0.361174,"twenty":-19.033611,"median":-2.529305,"eighty":-1.581602,"marketCap":46167735},{"date":"2025-05-16","current":-0.413868,"twenty":-18.983157,"median":-2.517417,"eighty":-1.570553,"marketCap":52903470},{"date":"2025-05-23","current":-0.397569,"twenty":-18.956686,"median":-2.511065,"eighty":-1.565684,"marketCap":50820078},{"date":"2025-05-30","current":-0.398364,"twenty":-18.956686,"median":-2.506353,"eighty":-1.557344,"marketCap":50921707},{"date":"2025-06-06","current":-0.432066,"twenty":-18.934707,"median":-2.496748,"eighty":-1.552878,"marketCap":55229642},{"date":"2025-06-13","current":-0.459362,"twenty":-18.82811,"median":-2.487817,"eighty":-1.543345,"marketCap":58718900},{"date":"2025-06-20","current":-0.380343,"twenty":-18.792944,"median":-2.47189,"eighty":-1.512958,"marketCap":48618120},{"date":"2025-06-27","current":-0.379857,"twenty":-18.77646,"median":-2.466124,"eighty":-1.50092,"marketCap":48556013},{"date":"2025-07-03","current":-0.350661,"twenty":-18.756222,"median":-2.462147,"eighty":-1.491592,"marketCap":44823975},{"date":"2025-07-11","current":-0.391827,"twenty":-18.714233,"median":-2.447602,"eighty":-1.450134,"marketCap":50086092},{"date":"2025-07-18","current":-0.362189,"twenty":-18.666566,"median":-2.437584,"eighty":-1.426088,"marketCap":46297594},{"date":"2025-07-25","current":-0.402825,"twenty":-18.614916,"median":-2.427509,"eighty":-1.404313,"marketCap":51491958},{"date":"2025-08-01","current":-0.344478,"twenty":-18.57067,"median":-2.414415,"eighty":-1.331539,"marketCap":44033529},{"date":"2025-08-08","current":-0.378532,"twenty":-18.555217,"median":-2.40586,"eighty":-1.303174,"marketCap":48386632},{"date":"2025-08-15","current":-0.431453,"twenty":-18.495038,"median":-2.398505,"eighty":-1.264735,"marketCap":53355154},{"date":"2025-08-22","current":-0.500815,"twenty":-18.432593,"median":-2.391933,"eighty":-1.15223,"marketCap":62260379},{"date":"2025-08-29","current":-0.596426,"twenty":-18.345676,"median":-2.388928,"eighty":-1.089015,"marketCap":74146451},{"date":"2025-09-05","current":-0.519027,"twenty":-18.208309,"median":-2.380157,"eighty":-1.042346,"marketCap":64524393},{"date":"2025-09-12","current":-0.550897,"twenty":-18.13871,"median":-2.37319,"eighty":-0.933078,"marketCap":68486417},{"date":"2025-09-19","current":-0.45984,"twenty":-18.050794,"median":-2.368712,"eighty":-0.866974,"marketCap":57166348},{"date":"2025-09-26","current":-0.55545,"twenty":-17.747105,"median":-2.355841,"eighty":-0.844127,"marketCap":69052420},{"date":"2025-10-03","current":-0.655613,"twenty":-17.440151,"median":-2.334462,"eighty":-0.822058,"marketCap":81504496},{"date":"2025-10-10","current":-0.637402,"twenty":-17.000576,"median":-2.32293,"eighty":-0.803413,"marketCap":79240483},{"date":"2025-10-17","current":-0.802246,"twenty":-12.566359,"median":-2.305151,"eighty":-0.783981,"marketCap":99733618},{"date":"2025-10-24","current":-0.918602,"twenty":-9.887148,"median":-2.283098,"eighty":-0.769176,"marketCap":114198799},{"date":"2025-10-31","current":-0.96147,"twenty":-9.675053,"median":-2.271252,"eighty":-0.769176,"marketCap":119528076},{"date":"2025-11-07","current":-0.826742,"twenty":-9.475046,"median":-2.248334,"eighty":-0.769176,"marketCap":102778919},{"date":"2025-11-14","current":-0.924726,"twenty":-8.921181,"median":-2.231397,"eighty":-0.761005,"marketCap":114960124},{"date":"2025-11-21","current":-1.179508,"twenty":-8.591499,"median":-2.22349,"eighty":-0.761005,"marketCap":131835932},{"date":"2025-11-28","current":-1.238483,"twenty":-7.441335,"median":-2.211557,"eighty":-0.761005,"marketCap":138427729},{"date":"2025-12-05","current":-1.135276,"twenty":-6.800346,"median":-2.199624,"eighty":-0.761005,"marketCap":126892085},{"date":"2025-12-12","current":-1.201623,"twenty":-6.589519,"median":-2.180749,"eighty":-0.761005,"marketCap":134307856},{"date":"2025-12-19","current":-1.415409,"twenty":-6.494033,"median":-2.171737,"eighty":-0.761005,"marketCap":158203119},{"date":"2025-12-26","current":-1.643939,"twenty":-6.442035,"median":-2.161079,"eighty":-0.761005,"marketCap":183746331},{"date":"2026-01-02","current":-2.137858,"twenty":-6.278478,"median":-2.157134,"eighty":-0.761005,"marketCap":238952628},{"date":"2026-01-09","current":-2.034651,"twenty":-5.905987,"median":-2.135692,"eighty":-0.761005,"marketCap":227416984},{"date":"2026-01-16","current":-1.584963,"twenty":-5.16762,"median":-2.12668,"eighty":-0.761005,"marketCap":177154534},{"date":"2026-01-23","current":-1.629195,"twenty":-4.915196,"median":-2.117669,"eighty":-0.761005,"marketCap":182098382},{"date":"2026-01-30","current":-1.400665,"twenty":-4.804582,"median":-2.104755,"eighty":-0.761005,"marketCap":156555170},{"date":"2026-02-06","current":-1.489128,"twenty":-4.73273,"median":-2.092063,"eighty":-0.761005,"marketCap":166442865},{"date":"2026-02-13","current":-1.651311,"twenty":-4.651425,"median":-2.081624,"eighty":-0.761005,"marketCap":184570305},{"date":"2026-02-20","current":-1.673427,"twenty":-4.581465,"median":-2.077118,"eighty":-0.761005,"marketCap":187042229},{"date":"2026-02-27","current":-2.115742,"twenty":-4.420745,"median":-2.071186,"eighty":-0.761005,"marketCap":236480704},{"date":"2026-03-06","current":-2.30004,"twenty":-4.268533,"median":-2.068362,"eighty":-0.761005,"marketCap":257080068},{"date":"2026-03-13","current":-2.790804,"twenty":-4.177774,"median":-2.068362,"eighty":-0.761005,"marketCap":277679433},{"date":"2026-03-20","current":-2.646132,"twenty":-3.850662,"median":-2.068362,"eighty":-0.761005,"marketCap":263284850},{"date":"2026-03-27","current":-2.687608,"twenty":-3.531119,"median":-2.068362,"eighty":-0.761005,"marketCap":267411572},{"date":"2026-04-02","current":-2.861804,"twenty":-3.389081,"median":-2.068362,"eighty":-0.761005,"marketCap":284743804},{"date":"2026-04-10","current":-3.649837,"twenty":-3.365285,"median":-2.068362,"eighty":-0.761005,"marketCap":363151518},{"date":"2026-04-17","current":-3.674723,"twenty":-3.365285,"median":-2.068362,"eighty":-0.761005,"marketCap":365627551},{"date":"2026-04-24","current":-4.44663,"twenty":-3.365285,"median":-2.068362,"eighty":-0.761005,"marketCap":442430780},{"date":"2026-05-01","current":-5.285426,"twenty":-3.365285,"median":-2.068362,"eighty":-0.761005,"marketCap":525889313},{"date":"2026-05-08","current":-5.204578,"twenty":-3.365285,"median":-2.068362,"eighty":-0.761005,"marketCap":517845117},{"date":"2026-05-15","current":-5.778859,"twenty":-3.365285,"median":-2.068362,"eighty":-0.761005,"marketCap":449583660},{"date":"2026-05-22","current":-5.597865,"twenty":-3.365285,"median":-2.068362,"eighty":-0.761005,"marketCap":435502740},{"date":"2026-05-29","current":-5.080742,"twenty":-3.358747,"median":-2.068234,"eighty":-0.758756,"marketCap":395271540},{"date":"2026-06-05","current":-5.201216,"twenty":-3.365285,"median":-2.068362,"eighty":-0.761005,"marketCap":404644179},{"date":"2026-06-12","current":-5.23946,"twenty":-3.365285,"median":-2.068362,"eighty":-0.761005,"marketCap":407619504},{"date":"2026-06-18","current":-5.545414,"twenty":-3.365285,"median":-2.068362,"eighty":-0.761005,"marketCap":431422103},{"date":"2026-06-26","current":-5.226712,"twenty":-3.358747,"median":-2.068234,"eighty":-0.758756,"marketCap":406627729},{"date":"2026-07-02","current":-6.259306,"twenty":-3.358747,"median":-2.068234,"eighty":-0.758756,"marketCap":486961500},{"date":"2026-07-10","current":-6.259306,"twenty":-3.358747,"median":-2.068234,"eighty":-0.758756,"marketCap":486961500},{"date":"2026-07-17","current":-5.328696,"twenty":-3.358747,"median":-2.068234,"eighty":-0.758756,"marketCap":414561929},{"date":"2026-07-24","current":-5.009995,"twenty":-3.358747,"median":-2.068234,"eighty":-0.758756,"marketCap":389767555},{"date":"2026-07-31","current":-6.437779,"twenty":-3.355365,"median":-2.068107,"eighty":-0.756508,"marketCap":500846349},{"date":"2026-08-07","current":-5.9661,"twenty":-3.355365,"median":-2.068107,"eighty":-0.756508,"marketCap":464150676},{"date":"2026-08-14","current":-9.12665,"twenty":-3.355365,"median":-2.068107,"eighty":-0.756508,"marketCap":552052798},{"date":"2026-08-21","current":-11.067766,"twenty":-3.355365,"median":-2.068107,"eighty":-0.756508,"marketCap":669467012},{"date":"2026-08-28","current":-10.795328,"twenty":-3.355365,"median":-2.068107,"eighty":-0.756508,"marketCap":652987824},{"date":"2026-09-04","current":-8.939349,"twenty":-3.355365,"median":-2.068107,"eighty":-0.756508,"marketCap":540723356},{"date":"2026-09-11","current":-7.951764,"twenty":-3.355365,"median":-2.068107,"eighty":-0.756508,"marketCap":480986299},{"date":"2026-09-18","current":-7.781491,"twenty":-3.355365,"median":-2.068107,"eighty":-0.756508,"marketCap":470686807},{"date":"2026-09-25","current":-6.793905,"twenty":-3.355365,"median":-2.068107,"eighty":-0.756508,"marketCap":410949750},{"date":"2026-10-02","current":-6.453359,"twenty":-3.355365,"median":-2.068107,"eighty":-0.756508,"marketCap":390350765},{"date":"2026-10-09","current":-6.606605,"twenty":-3.355365,"median":-2.068107,"eighty":-0.756508,"marketCap":399620309},{"date":"2026-10-12","current":-6.623632,"twenty":-3.355365,"median":-2.068107,"eighty":-0.756508,"marketCap":400650258}],"updateTime":1791946246073},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PRLD\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2675836669","title":"Analysts Offer Insights on Healthcare Companies: NovaBridge Biosciences (NBP) and Prelude Therapeutics (PRLD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2675836669","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675836669?lang=en_us&edition=fundamental","pubTime":"2026-10-14 00:40","pubTimestamp":1791909615,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on NovaBridge Biosciences (NBP) and Prelude Therapeutic...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-novabridge-biosciences-nbp-and-prelude-therapeutics-prld-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-novabridge-biosciences-nbp-and-prelude-therapeutics-prld-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","LU0029874061.USD","XBI","BK4505","HCSG","BK4588","NBP","LU0128526141.USD","XLV","BK4137","PRLD","BK4585","LABU","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675366648","title":"H.C. Wainwright ‘highly enthusiastic’ on Prelude collaboration with Lilly","url":"https://stock-news.laohu8.com/highlight/detail?id=2675366648","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675366648?lang=en_us&edition=fundamental","pubTime":"2026-10-14 00:25","pubTimestamp":1791908728,"startTime":"0","endTime":"0","summary":"H.C. Wainwright reiterates a Buy rating on Prelude Therapeutics (PRLD) with an $8 price target after the company announced a clinical trial collabo...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/h-c-wainwright-highly-enthusiastic-on-prelude-collaboration-with-lilly-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/h-c-wainwright-highly-enthusiastic-on-prelude-collaboration-with-lilly-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MEDX","PRLD","BK4505","GDOC","BK4139","HYLG","NVIB","IDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675356864","title":"Prelude Therapeutics Partners with Lilly to Test Prt13722 Combos with Verzenio, Imlunestrant in Phase 1 Breast Cancer Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2675356864","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675356864?lang=en_us&edition=fundamental","pubTime":"2026-10-13 19:06","pubTimestamp":1791889593,"startTime":"0","endTime":"0","summary":"Prelude Therapeutics partners with Lilly to test PRT13722 combos with Verzenio, imlunestrant in Phase 1 breast cancer trialPrelude Therapeutics entered a clinical trial collaboration and supply agreem","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261013:nNDL4NWFn7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014005.SGD","PRLD","LU0314104364.USD","SG9999014039.USD","BK4112","IE00B64PRP62.GBP","IE00BKPKM429.USD","LU2210149790.SGD","IE00BN0W2T93.GBP","NDAQ","IE00BQXX3D17.EUR","LU2095319765.USD","BCDF","IE00BN0W2V16.EUR","IE00BQXX3C00.GBP","BK4585","BK4588","IE00BGHQF748.EUR","SG9999014013.SGD","IE00B3QW5Z07.USD","LU2210150020.SGD","SG9999014021.USD","BK4505","IE00BQXX3F31.USD","IE00BN0W2W23.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675557303","title":"Prelude Announces Clinical Trial Collaboration and Supply Agreement with Lilly to Evaluate Kat6a Selective Degrader Prt13722 in Combination with Verzenio® and Inluriyo® in Patients with Hr+/Her2- Breast Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2675557303","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675557303?lang=en_us&edition=fundamental","pubTime":"2026-10-13 19:01","pubTimestamp":1791889260,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261013:nTUA5NHM4D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4505","PRLD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675355758","title":"Prelude Therapeutics Incorporated - Agreement Supports Evaluation of Prt13722 with Abemaciclib and Imlunestrant in Phase 1 Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2675355758","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675355758?lang=en_us&edition=fundamental","pubTime":"2026-10-13 19:01","pubTimestamp":1791889260,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261013:nTUA5NHM4D:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4505","BK4139","PRLD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675355739","title":"Prelude Therapeutics Incorporated - Maintains Full Global Development and Commercial Rights to Prt13722","url":"https://stock-news.laohu8.com/highlight/detail?id=2675355739","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675355739?lang=en_us&edition=fundamental","pubTime":"2026-10-13 19:01","pubTimestamp":1791889260,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261013:nTUA5NHM4D:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PRLD","BK4505","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668591955","title":"Prelude Therapeutics Incorporated : JP Morgan Initiates Coverage with Overweight Rating; Price Target $12","url":"https://stock-news.laohu8.com/highlight/detail?id=2668591955","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668591955?lang=en_us&edition=fundamental","pubTime":"2026-09-17 12:21","pubTimestamp":1789618904,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260917:nFWN45807V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PRLD","BK4139","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666524738","title":"Prelude Therapeutics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2666524738","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666524738?lang=en_us&edition=fundamental","pubTime":"2026-09-11 19:01","pubTimestamp":1789124460,"startTime":"0","endTime":"0","summary":"WILMINGTON, Del., Sept.  11, 2026 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Prelude) (Nasdaq: PRLD), a clinical-stage precision oncology company, announced today that the Company will par","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/11/3360242/0/en/prelude-therapeutics-to-participate-in-the-h-c-wainwright-28th-annual-global-investment-conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRLD","BK4139","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666598724","title":"Prelude Therapeutics IND Cleared for Novel Breast Cancer Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2666598724","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666598724?lang=en_us&edition=fundamental","pubTime":"2026-09-10 19:59","pubTimestamp":1789041564,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Prelude Therapeutics ( ($PRLD) ). On September 10, 2026, Prelude Therapeutics announced that the U.S. Food and ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/prelude-therapeutics-ind-cleared-for-novel-breast-cancer-drug?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/prelude-therapeutics-ind-cleared-for-novel-breast-cancer-drug?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4505","PRLD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666856021","title":"Prelude Therapeutics receives FDA clearance for PRT13722 IND application","url":"https://stock-news.laohu8.com/highlight/detail?id=2666856021","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666856021?lang=en_us&edition=fundamental","pubTime":"2026-09-10 19:10","pubTimestamp":1789038614,"startTime":"0","endTime":"0","summary":"Prelude Therapeutics (PRLD) announced that the FDA cleared the company to proceed with a Phase 1 study under its Investigational New Drug Applicati...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/prelude-therapeutics-receives-fda-clearance-for-prt13722-ind-application-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/prelude-therapeutics-receives-fda-clearance-for-prt13722-ind-application-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4588","BK4585","BK4505","PRLD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666375560","title":"Prelude Therapeutics Says FDA Clears IND for Prt13722 in Hr+/her2- Breast Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2666375560","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666375560?lang=en_us&edition=fundamental","pubTime":"2026-09-10 19:03","pubTimestamp":1789038201,"startTime":"0","endTime":"0","summary":"Prelude Therapeutics says FDA clears IND for PRT13722 in HR+/HER2- breast cancerPrelude Therapeutics received FDA clearance for its IND for PRT13722, an oral KAT6A selective degrader for HR+/HER2- bre","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nNDL9By3Fj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BQXX3F31.USD","BK4588","NDAQ","SG9999014013.SGD","LU2210149790.SGD","IE00BN0W2T93.GBP","BCDF","SG9999014039.USD","IE00BQXX3D17.EUR","SG9999014005.SGD","BK4112","BK4585","BK4505","LU2095319765.USD","IE00B64PRP62.GBP","SG9999014021.USD","LU2210150020.SGD","IE00BQXX3C00.GBP","IE00BN0W2V16.EUR","PRLD","LU0314104364.USD","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","IE00BKPKM429.USD","BK4139","IE00BN0W2W23.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666893560","title":"Prelude Therapeutics Incorporated - Expects to Begin Enrolling Patients in Q4 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2666893560","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666893560?lang=en_us&edition=fundamental","pubTime":"2026-09-10 19:01","pubTimestamp":1789038060,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nTUA5JLXDK:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4505","PRLD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666556089","title":"Prelude Therapeutics Receives FDA Clearance of Investigational New Drug (Ind) Application for Prt13722, Its First-in-Class Oral Kat6a Selective Degrader","url":"https://stock-news.laohu8.com/highlight/detail?id=2666556089","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666556089?lang=en_us&edition=fundamental","pubTime":"2026-09-10 19:01","pubTimestamp":1789038060,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nTUA5JLXDK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4505","PRLD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661366239","title":"Prelude Therapeutics Stock Rises on Narrower 2Q Loss, Plans to Start Trial for Breast Cancer Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2661366239","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661366239?lang=en_us&edition=fundamental","pubTime":"2026-08-21 01:23","pubTimestamp":1787246580,"startTime":"0","endTime":"0","summary":"Shares of Prelude Therapeutics gained after the company recorded a narrower loss in the second quarter and shared plans to start a trial for a potential breast cancer treatment.The stock rose 13% to $6.55 on Thursday. Shares have more than doubled year to date.The clinical-stage oncology company posted a second-quarter loss of $13.9 million, or 14 cents a share, compared with a loss of $31.2 million, or 41 cents a share, a year earlier. Analysts polled by FactSet expected a loss of 20 cents a share.Revenue was $5.7 million, compared with $0 a year ago.Prelude said it has made progress on its three core programs, and expects to initiate the first clinical trial of PRT13722 in hormone receptor-positive breast cancer in the fourth quarter. The start of the Phase 1 study is pending clearance of the company's investigational new drug application.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Prelude Therapeutics Stock Rises on Narrower 2Q Loss, Plans to Start Trial for Breast Cancer Drug","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRLD","BK4505","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660411424","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2660411424","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660411424?lang=en_us&edition=fundamental","pubTime":"2026-08-19 18:00","pubTimestamp":1787133600,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.Company                                   Symbol     Quarter  Mean  Report Time. ·Estee Lauder Co.                                  4Q       .32   6:00 AM. ·FLEX LNG Ltd                                    2Q       .62   1:00 AM. ·Adv Auto Parts                                   2Q       .81   6:30 AM. ·Atour Life ADR                                  2Q       .58   6:00 AM","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ROST","DOMO","PDD","BMA","OSIS","SCSC","ALVO","MRKR","GGAL","NMTC","BJ","NMM","NTES","VIPS","FUTU","BOX","ANF","ADI","ATAT","LYTS","BNS","KC","FLUX","JOYY","AAP","BILL","EL","FLNG","HEI","LOW","NTHI","INTU","BZ","FLO","HEI.A","NDSN","MZTI","BEEM","PICS","PRLD","NCNO","DKS","BEKE","BMO","COTY","CDLR","ATHM","BABA","DE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659971152","title":"Ovid Therapeutics Q2 Revenue Beats Estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2659971152","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659971152?lang=en_us&edition=fundamental","pubTime":"2026-08-13 20:44","pubTimestamp":1786625080,"startTime":"0","endTime":"0","summary":"Ovid Therapeutics Q2 revenue beats estimatesOverviewUS biopharma firm's Q2 revenue beat analyst expectationsCompany posted Q2 net loss as operating expenses rose on clinical study activityOvid secured","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nL1N44A0LF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NKTX","BK4505","BK4139","CABA","OVID","PRLD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658908525","title":"Prelude Therapeutics Incorporated Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2658908525","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658908525?lang=en_us&edition=fundamental","pubTime":"2026-08-12 21:31","pubTimestamp":1786541515,"startTime":"0","endTime":"0","summary":"Prelude Therapeutics Incorporated reports results for the quarter ended June 30 - Earnings SummaryPrelude Therapeutics IncorporatedPRLD.OQreported a quarterly adjusted loss of 14 cents per share for t","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nL8N4491D5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4505","PRLD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658094581","title":"Cardiff Oncology Q2 Operating Expenses Fall on Lower R&D Costs","url":"https://stock-news.laohu8.com/highlight/detail?id=2658094581","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658094581?lang=en_us&edition=fundamental","pubTime":"2026-08-12 04:36","pubTimestamp":1786480574,"startTime":"0","endTime":"0","summary":"CORRECTED-Cardiff Oncology Q2 operating expenses fall on lower R&D costsCorrects to clarify second and third result drivers pertain to H1, not Q2OverviewUS biotech firm's Q2 operating expenses fell yr","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nL1N448110:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4505","PRLD","BK4539","TOVX","CRDF","ERAS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658943113","title":"Bolt Biotherapeutics Q2 Net Loss Narrows on Restructuring and Lower Research Activity","url":"https://stock-news.laohu8.com/highlight/detail?id=2658943113","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658943113?lang=en_us&edition=fundamental","pubTime":"2026-08-12 04:24","pubTimestamp":1786479858,"startTime":"0","endTime":"0","summary":"Bolt Biotherapeutics Q2 net loss narrows on restructuring and lower research activityOverviewUS cancer immunotherapy developer's Q2 collaboration revenue fell sharply from prior yearNet loss narrowed ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nL1N4480ZE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BOLT","PRLD","BK4505","TOVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658992472","title":"Prelude Therapeutics Q2 EPS $(0.14) Beats $(0.20) Estimate, Sales $5.704M","url":"https://stock-news.laohu8.com/highlight/detail?id=2658992472","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658992472?lang=en_us&edition=fundamental","pubTime":"2026-08-11 19:23","pubTimestamp":1786447422,"startTime":"0","endTime":"0","summary":"Prelude Therapeutics (NASDAQ:PRLD) reported quarterly losses of $(0.14) per share which beat the analyst consensus estimate of $(0.20) by 30 percent. This is a 65.85 percent increase over losses of $(0.41) per share","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/61103719/prelude-therapeutics-q2-eps-0-14-beats-0-20-estimate-sales-5-704m","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRLD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":52,"code":"91000000","status":"200"}]}}